194 related articles for article (PubMed ID: 26686258)
1. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
Mounier M; Bossard N; Remontet L; Belot A; Minicozzi P; De Angelis R; Capocaccia R; Iwaz J; Monnereau A; Troussard X; Sant M; Maynadié M; Giorgi R; ;
Lancet Haematol; 2015 Nov; 2(11):e481-91. PubMed ID: 26686258
[TBL] [Abstract][Full Text] [Related]
2. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
3. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
De Angelis R; Sant M; Coleman MP; Francisci S; Baili P; Pierannunzio D; Trama A; Visser O; Brenner H; Ardanaz E; Bielska-Lasota M; Engholm G; Nennecke A; Siesling S; Berrino F; Capocaccia R;
Lancet Oncol; 2014 Jan; 15(1):23-34. PubMed ID: 24314615
[TBL] [Abstract][Full Text] [Related]
4. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study.
Gatta G; Botta L; Rossi S; Aareleid T; Bielska-Lasota M; Clavel J; Dimitrova N; Jakab Z; Kaatsch P; Lacour B; Mallone S; Marcos-Gragera R; Minicozzi P; Sánchez-Pérez MJ; Sant M; Santaquilani M; Stiller C; Tavilla A; Trama A; Visser O; Peris-Bonet R;
Lancet Oncol; 2014 Jan; 15(1):35-47. PubMed ID: 24314616
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
7. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.
De Angelis R; Minicozzi P; Sant M; Dal Maso L; Brewster DH; Osca-Gelis G; Visser O; Maynadié M; Marcos-Gragera R; Troussard X; Agius D; Roazzi P; Meneghini E; Monnereau A;
Eur J Cancer; 2015 Oct; 51(15):2254-2268. PubMed ID: 26421827
[TBL] [Abstract][Full Text] [Related]
8. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
9. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
11. Trends in net survival from colon cancer in six European Latin countries: results from the SUDCAN population-based study.
Faivre J; Bossard N; Jooste V;
Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S40-S47. PubMed ID: 28005604
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.
Sant M; Vener C; Lillini R; Rossi S; Bonfarnuzzo S; Marcos-Gragera R; Maynadié M; Innos K; Paapsi K; Visser O; Bernasconi A; Demuru E; Di Benedetto C; Mousavi SM; Blum M; Went P; Serraino D; Bennett D; Sánchez MJ; De Angelis R;
Lancet Oncol; 2024 May; ():. PubMed ID: 38703784
[TBL] [Abstract][Full Text] [Related]
13. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
[TBL] [Abstract][Full Text] [Related]
14. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.
Trama A; Botta L; Foschi R; Ferrari A; Stiller C; Desandes E; Maule MM; Merletti F; Gatta G;
Lancet Oncol; 2016 Jul; 17(7):896-906. PubMed ID: 27237614
[TBL] [Abstract][Full Text] [Related]
15. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
Minicozzi P; Walsh PM; Sánchez MJ; Trama A; Innos K; Marcos-Gragera R; Dimitrova N; Botta L; Johannesen TB; Rossi S; Sant M;
Eur J Cancer; 2018 Apr; 93():127-137. PubMed ID: 29518726
[TBL] [Abstract][Full Text] [Related]
16. Trends in net survival from stomach cancer in six European Latin countries: results from the SUDCAN population-based study.
Glória L; Bossard N; Bouvier AM; Mayer-da-Silva A; Faivre J; Miranda A;
Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S32-S39. PubMed ID: 28005603
[TBL] [Abstract][Full Text] [Related]
17. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Locke FL; Ghobadi A; Jacobson CA; Miklos DB; Lekakis LJ; Oluwole OO; Lin Y; Braunschweig I; Hill BT; Timmerman JM; Deol A; Reagan PM; Stiff P; Flinn IW; Farooq U; Goy A; McSweeney PA; Munoz J; Siddiqi T; Chavez JC; Herrera AF; Bartlett NL; Wiezorek JS; Navale L; Xue A; Jiang Y; Bot A; Rossi JM; Kim JJ; Go WY; Neelapu SS
Lancet Oncol; 2019 Jan; 20(1):31-42. PubMed ID: 30518502
[TBL] [Abstract][Full Text] [Related]
19. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.
Monnereau A; Troussard X; Belot A; Guizard AV; Woronoff AS; Bara S; Lapôtre-Ledoux B; Iwaz J; Tretarre B; Maynadié M;
Int J Cancer; 2013 May; 132(10):2378-87. PubMed ID: 23034773
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
